Combined radiation and gene therapy for brain tumors with adenovirus-mediated transfer of cytosine deaminase and uracil phosphoribosyltransferase genes

Cancer Gene Therapy

Volumn 9, Issue 10, 2002, Pages 840-845

  Kambara, Hirokazu ^a   Tamiya, Takashi ^a   Ono, Yasuhiro ^a   Ohtsuka, Shinji ^a   Terada, Kinya ^a   Adachi, Yoshiaki ^a   Ichikawa, Tomotsugu ^a   Hamada, Hirofumi ^b   Ohmoto, Takashi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Adenovirus vector; Cytosine deaminase; Gene therapy; Glioma; Radiation; Uracil phosphoribosyltransferase

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; URACIL PHOSPHORIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN TUMOR; CANCER RADIOTHERAPY; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; GLIOMA; MALE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RAT;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BRAIN; BRAIN NEOPLASMS; CELL DIVISION; COMBINED MODALITY THERAPY; CYTOSINE DEAMINASE; FLOW CYTOMETRY; FLUOROURACIL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLIOSARCOMA; LAC OPERON; MALE; NUCLEOSIDE DEAMINASES; PENTOSYLTRANSFERASES; RADIOTHERAPY; RATS; RATS, WISTAR; SURVIVAL RATE; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; ANIMALIA;

EID: 0036789520     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700506     Document Type: Article

References (23)

1. Ichikawa T, Tamiya T, Adachi Y, et al. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus. Cancer Gene Ther. 2000;7:74-82.
2. Adachi Y, Tamiya T, Ichikawa T, et al. Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine. Hum Gene Ther. 2000;11:77-89.
3. Tamiya T, Ono Y, Wei MX, et al. Escherichia coli gpt gene sensitizes rat glioma cells to killing by 6-thioxanthine or 6- thioguanine. Cancer Gene Ther. 1996;3:155-162.
4. Nishiyama T, Kawamura Y, Kawamoto K, et al. Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules. Cancer Res. 1985;45:1753-1761.
5. Ohwada A, Hirshowtiz EA, Cristal RG. Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver. Hum Gene Ther. 1996;7:1567-1576.
6. Hirshowitz EA, Ohwada A, Pascal WR, et al. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induced chemosensitivity to 5-fluorocytosine. Hum Gene Ther. 1995;6:1055-1063.
7. Lan K-H, Kanai F, Shiratori Y, et al. In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma. Cancer Res. 1997;57:4279-4284.
8. Kanai F, Lan K-H, Shiratori Y, et al. In vivo gene therapy for alfa-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene. Cancer Res. 1997;57:461-465.
9. Dong Y, Wen P, Manome Y, et al. In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum Gene Ther. 1996;7:713-720.
10. Kanai F, Kawakami T, Hamada H, et al. Adenovirus-mediated transduction of Escherichia coli uracil phosphoribosyltransferase gene sensitizes cancer cells to low concentration of 5-fluorouracil. Cancer Res. 1998;58:1946-1951.
11. Tiraby M, Cazaux C, Baron M, et al. Concomitant expression of E. Coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine. FEMS Microbiol Lett. 1998;167:41-49.
12. Broaddus WC, Liu Y, Steele LL, et al. Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction. J Neurosurg. 1999;91:997-1004.
13. Badie B, Goh CS, Klaver J, et al. Combined radiation and p53 gene therapy of malignant glioma cells. Cancer Gene Ther. 1999;6:155-162.
14. Valerie K, Brust D, Farnworth J, et al. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir. Cancer Gene Ther. 2000;7:879-884.
15. Marples B, Scott SD, Hendry JH, et al. Development of synthetic promoters for radiation-mediated gene therapy. Gene Ther. 2000;7:511-517.
16. Rogulski KR, Kim JH, Kim SH, et al. Glioma cells transduced with an E. Coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum Gene Ther. 1997;8:73-85.
17. Kim SH, Kim JH, Kolozsvary A, et al. Preferential radiosensitization of 9 L glioma cells transduced with HSV-tk gene by acyclovir. J Neuro-Oncol. 1997;33:189-194.
18. Kim JH, Kim SH, Kolozsvary A, et al. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9 L gliosarcoma cells in vitro and in vivo by antiviral agents. Int J Radiat Oncol Biol Phys. 1995;33: 861-868.
19. Freytag SO, Rogulski KR, Paielli DL, et al. A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy. Hum Gene Ther. 1998;9:1323-1333.
20. Pederson LC, Bushsbaum DJ, Vickers SM, et al. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. Cancer Res. 1997;57:4325-4332.
21. Khil MS, Kim JH, Mullen CA, et al. Radiosensitization by 5-fluorocytosine of human colorectal carcinoma in culture transduced with cytosine deaminase gene. Clin Cancer Res. 1996;2:53-57.
22. Goodman JC, Trask TW, Chen S-H. Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies. Hum Gene Ther. 1996;7:1241-1250.
23. Smith JG, Raper SE, Wheeldon EB. Intracranial administration of adenovirus-expressing HSV-TK in combination with ganciclovir produces a dose-dependent, self-limiting inflammatory response. Hum Gene Ther. 1997;8:943-9564.